Bruno Robert

Title: Bruno Robert: Innovator in Immunology

Introduction

Bruno Robert is a notable inventor based in Saint Hippolyte du Four, France. He has made significant contributions to the field of immunology, particularly through his innovative patent related to CD1d molecules. His work aims to enhance immune responses, which can have profound implications for treating various diseases.

Latest Patents

Bruno Robert holds a patent for "Targeted CD1d molecules." This invention is directed to a compound that comprises one or more CD1d complexes in association with an antibody specific for a cell surface marker. The CD1d complexes include a CD1d molecule, a β2-microglobulin molecule, and may also contain an antigen bound to the CD1d binding groove. The invention further outlines methods for inhibiting or stimulating immune responses using the CD1d-antibody compounds, particularly in the context of anti-tumor and autoimmunity responses.

Career Highlights

Bruno Robert is currently associated with Vaccinex, Inc., where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions in the field of immunotherapy, contributing to the development of new treatments for various health conditions.

Collaborations

Bruno collaborates with talented individuals such as Alena Donda and Valerie Cesson, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in immunology.

Conclusion

Bruno Robert's contributions to immunology through his patent on targeted CD1d molecules exemplify the importance of innovation in medical research. His work has the potential to significantly influence the treatment of immune-related diseases.